RSS
Atom • ISSN 1472-4683 • Subscribe • About
2003
- Postnatal transmission of HIV to breastfed infants following short course ZDV regimen PMTCT and maternal health - 1 October 2003
- Influence of mothers’ health and survival on children’s survival PMTCT and maternal health - 1 October 2003
- Higher than currently recommended NVP dose shows greater efficacy in HIV-infected children Paediatric care - 1 October 2003
- Time on anti-HIV therapy is a protective factor for liver fibrosis in HIV-HCV coinfected patients Hepatitis coinfection - 1 October 2003
- HIV-HCV co-infected patients have poorer response to HCV therapy Hepatitis coinfection - 1 October 2003
- CDC study shows rifampin/pyrazinamide therapy can cause severe liver damage TB coinfection - 1 October 2003
- Impact of the HIV epidemic in sub-Saharan Africa on the pattern of HIV in the UK Other news - 1 October 2003
- EMEA public statement on early virologic non-response in patients with HIV infection treated with tenofovir in combination with lamivudine and abacavir Treatment alerts - 1 September 2003
- XII International HIV Drug Resistance Workshop, Los Cabos, Mexico, 10-14 June 2003 Conference reports - Resistance - Conference index - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Transmission of drug resistance – at 11% in Europe and 17% in the UK Conference reports - Resistance - Transmission and prevention - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- HIV coinfection, reinfection and superinfection Conference reports - Hepatitis coinfection - Resistance - Transmission and prevention - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Single-dose nevirapine resistance in over 75% of mothers Conference reports - PMTCT and maternal health - Resistance - Women's health - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Transmission of drug resistant virus does not revert to wild-type and does not appear ‘less fit’ Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Standard genotype assays may miss 75% of mutations when present in less than 35% of plasma sample Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Low-level resistance and minority populations: cross resistance between nevirapine and efavirenz occurs even in the absence of genotypic mutations found using population sequencing Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Persistent effect of d4T and 3TC, but not NNRTIs in the presence of associated genotypic mutations Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Replicative capacity results complicated by minority wild-type virus Conference reports - Resistance - Virology - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Response to STI is determined by virus rather than immunological response Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Why resistance rarely develops with viral suppression <50 copies/mL Conference reports - Resistance - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Long-term persistence of distinct mutations in genital tract Conference reports - Resistance - Women's health - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Severe efavirenz psychotic events Conference reports - Side effects - Lipodystrophy Workshop (IWADRW) 5 Paris 2003 - 1 September 2003
- 2nd IAS Conference on HIV Pathogenesis and Treatment, 13-16 July 2003, Paris Conference reports - Conference index - IAS 2 Paris 2003 - 1 September 2003
- Uridine as a potential treatment for NRTI related mitochondrial toxicity Conference reports - PK and drug interactions - Side effects - Lipodystrophy Workshop (IWADRW) 5 Paris 2003 - 1 September 2003
- Long term exposure to nucleoside analogues and peripheral nerve function Conference reports - Side effects - IAS 2 Paris 2003 - 1 September 2003
- First results from ESPRIT study: CD4 response to IL-2 is associated with higher nadir and baseline CD4 and younger age Basic science and immunology - Conference reports - 1 September 2003
- Studies highlight problems of rectal disease in HIV-positive patients Conference reports - Opportunistic infections and complications - IAS 2 Paris 2003 - 1 September 2003
- Appointment of industry executive to supervise US AIDS initiative provokes criticism Treatment access - 1 September 2003
- Protease inhibitors and Kaposi’s sarcoma (KS): KS relapse seen after switch from PI to NNRTI Opportunistic infections and complications - 1 September 2003
- World Health Assembly approves resolution supporting public health considerations in drug policy Treatment access - 1 July 2003
- Adherence is not a barrier to successful antiretroviral therapy in South Africa Treatment access - 1 July 2003
- Is stress associated with CIN progression in HIV-positive women? Cancer and HIV - Women's health - 1 July 2003
- Lamotrigine shows some benefit for HIV-associated painful sensory neuropathies Side effects - 1 July 2003
- T cell activation is associated with decreased CD4+ T cell gains during ARV therapy Basic science and immunology - 1 July 2003
- Structured treatment interruptions trial shows no benefit Basic science and immunology - 1 July 2003
- Tobacco use increases risk for pulmonary diseases and weakens response to therapy in patients on HAART Opportunistic infections and complications - 1 July 2003
- EBV levels in HIV-positive patients are not reduced by HAART Cancer and HIV - Opportunistic infections and complications - 1 July 2003